Constipation resident survival guide: Difference between revisions
No edit summary |
|||
Line 3: | Line 3: | ||
==Definition== | ==Definition== | ||
[[Constipation]] is a syndrome that is characterized by difficulty in passing [[stool]], by infrequent bowel movements, by hard stool, or by a feeling of incomplete evacuation that occurs either in isolation or secondary to another underlying disorder.<ref name="pmid16008640">{{cite journal| author=American College of Gastroenterology Chronic Constipation Task Force| title=An evidence-based approach to the management of chronic constipation in North America. | journal=Am J Gastroenterol | year= 2005 | volume= 100 Suppl 1 | issue= | pages= S1-4 | pmid=16008640 | doi=10.1111/j.1572-0241.2005.50613_1.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16008640 }} </ref><ref name="pmid11113098">{{cite journal| author=Locke GR, Pemberton JH, Phillips SF| title=American Gastroenterological Association Medical Position Statement: guidelines on constipation. | journal=Gastroenterology | year= 2000 | volume= 119 | issue= 6 | pages= 1761-6 | pmid=11113098 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11113098 }} </ref> | [[Constipation]] is a syndrome that is characterized by difficulty in passing [[stool]], by infrequent bowel movements, by hard stool, or by a feeling of incomplete evacuation that occurs either in isolation or secondary to another underlying disorder.<ref name="pmid23261065">{{cite journal| author=Bharucha AE, Pemberton JH, Locke GR| title=American Gastroenterological Association technical review on constipation. | journal=Gastroenterology | year= 2013 | volume= 144 | issue= 1 | pages= 218-38 | pmid=23261065 | doi=10.1053/j.gastro.2012.10.028 | pmc=PMC3531555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23261065 }} </ref><ref name="pmid16008640">{{cite journal| author=American College of Gastroenterology Chronic Constipation Task Force| title=An evidence-based approach to the management of chronic constipation in North America. | journal=Am J Gastroenterol | year= 2005 | volume= 100 Suppl 1 | issue= | pages= S1-4 | pmid=16008640 | doi=10.1111/j.1572-0241.2005.50613_1.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16008640 }} </ref><ref name="pmid11113098">{{cite journal| author=Locke GR, Pemberton JH, Phillips SF| title=American Gastroenterological Association Medical Position Statement: guidelines on constipation. | journal=Gastroenterology | year= 2000 | volume= 119 | issue= 6 | pages= 1761-6 | pmid=11113098 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11113098 }} </ref> | ||
{|class="wikitable" | |||
! Rome III criteria<ref name="pmid23261065">{{cite journal| author=Bharucha AE, Pemberton JH, Locke GR| title=American Gastroenterological Association technical review on constipation. | journal=Gastroenterology | year= 2013 | volume= 144 | issue= 1 | pages= 218-38 | pmid=23261065 | doi=10.1053/j.gastro.2012.10.028 | pmc=PMC3531555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23261065 }} </ref><ref name="Longstreth-2006">{{Cite journal | last1 = Longstreth | first1 = GF. | last2 = Thompson | first2 = WG. | last3 = Chey | first3 = WD. | last4 = Houghton | first4 = LA. | last5 = Mearin | first5 = F. | last6 = Spiller | first6 = RC. | title = Functional bowel disorders. | journal = Gastroenterology | volume = 130 | issue = 5 | pages = 1480-91 | month = Apr | year = 2006 | doi = 10.1053/j.gastro.2005.11.061 | PMID = 16678561 }}</ref>!! Pharmacologic studies based criteria<ref name="pmid23261065">{{cite journal| author=Bharucha AE, Pemberton JH, Locke GR| title=American Gastroenterological Association technical review on constipation. | journal=Gastroenterology | year= 2013 | volume= 144 | issue= 1 | pages= 218-38 | pmid=23261065 | doi=10.1053/j.gastro.2012.10.028 | pmc=PMC3531555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23261065 }} </ref><ref name="Lembo-2010">{{Cite journal | last1 = Lembo | first1 = AJ. | last2 = Kurtz | first2 = CB. | last3 = Macdougall | first3 = JE. | last4 = Lavins | first4 = BJ. | last5 = Currie | first5 = MG. | last6 = Fitch | first6 = DA. | last7 = Jeglinski | first7 = BI. | last8 = Johnston | first8 = JM. | title = Efficacy of linaclotide for patients with chronic constipation. | journal = Gastroenterology | volume = 138 | issue = 3 | pages = 886-95.e1 | month = Mar | year = 2010 | doi = 10.1053/j.gastro.2009.12.050 | PMID = 20045700 }}</ref> | |||
|- | |||
| Symptoms for ≥6 months and ≥2 of the following for the past 3 months:<br> | |||
● Straining during defecation<br> | |||
● Hard or lumpy stools<br> | |||
● Sensation of incomplete evacuation during defecation<br> | |||
● Sensation of anorectal obstruction/blockade during defecation<br> | |||
● Manual maneuvers to facilitate defecations with <3 defecations/week<br> | |||
● Absence of loose stools | |||
|| Spontaneous bowel movements <3 per week and ≥1 of the following for at least 12 weeks during the past 12 months: | |||
● Straining during more than one-fourth of defecation<br> | |||
● Lumpy or hard stools in more than one-fourth of defecation<br> | |||
● Sensation of incomplete evacuation in more than one-fourth of defecation<br> | |||
● Absence of loose stools or watery spontaneous bowel movements | |||
|- | |||
|} | |||
==Causes== | ==Causes== | ||
Line 25: | Line 43: | ||
==Management== | ==Management== | ||
The algorithm is based on the [[American Gastroenterological Association]] guidelines for management of [[constipation]] in adults.<ref name="pmid23261065">{{cite journal| author=Bharucha AE, Pemberton JH, Locke GR| title=American Gastroenterological Association technical review on constipation. | journal=Gastroenterology | year= 2013 | volume= 144 | issue= 1 | pages= 218-38 | pmid=23261065 | doi=10.1053/j.gastro.2012.10.028 | pmc=PMC3531555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23261065 }} </ref><ref name=" | The algorithm is based on the [[American Gastroenterological Association]] guidelines for management of [[constipation]] in adults.<ref name="pmid23261065">{{cite journal| author=Bharucha AE, Pemberton JH, Locke GR| title=American Gastroenterological Association technical review on constipation. | journal=Gastroenterology | year= 2013 | volume= 144 | issue= 1 | pages= 218-38 | pmid=23261065 | doi=10.1053/j.gastro.2012.10.028 | pmc=PMC3531555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23261065 }} </ref><ref name="Bharucha-2013">{{Cite journal | last1 = Bharucha | first1 = AE. | last2 = Dorn | first2 = SD. | last3 = Lembo | first3 = A. | last4 = Pressman | first4 = A. | title = American Gastroenterological Association medical position statement on constipation. | journal = Gastroenterology | volume = 144 | issue = 1 | pages = 211-7 | month = Jan | year = 2013 | doi = 10.1053/j.gastro.2012.10.029 | PMID = 23261064 }}</ref> | ||
===Initial Evaluation=== | ===Initial Evaluation=== |
Revision as of 22:59, 13 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]
Definition
Constipation is a syndrome that is characterized by difficulty in passing stool, by infrequent bowel movements, by hard stool, or by a feeling of incomplete evacuation that occurs either in isolation or secondary to another underlying disorder.[1][2][3]
Rome III criteria[1][4] | Pharmacologic studies based criteria[1][5] |
---|---|
Symptoms for ≥6 months and ≥2 of the following for the past 3 months: ● Straining during defecation |
Spontaneous bowel movements <3 per week and ≥1 of the following for at least 12 weeks during the past 12 months:
● Straining during more than one-fourth of defecation |
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
- Atropine poisoning
- Hypokalemia
- Lead poisoning
- Opium poisoning
- Severe dehydration
- Spinal cord injury
- Superior mesenteric artery occlusion
Common Causes
- Hardening of the feces: Improper mastication, low dietary fiber, dehydration and medications (aluminium, calcium, diuretic, iron).
- Paralysis or slowed transit: Hypothyroidism, hypokalemia, injured anal sphincter, medications (loperamide, codeine, morphine, tricyclic antidepressants) and severe systemic illness due to other causes.
- Constriction, where part of the intestine or rectum is narrowed or blocked: Diverticulosis, pelvic masses and stenosis.
- Psychosomatic constipation: Functional constipation and irritable bowel syndrome.[6]
- Smoking cessation[7]
- Abdominal surgery and childbirth
Management
The algorithm is based on the American Gastroenterological Association guidelines for management of constipation in adults.[1][8]
Initial Evaluation
Characterize the symptom: ❑ Any desire to defecate but an inability to pass a stool Associated symptoms: ❑ Abdominal pain or abdominal discomfort:
❑ Abdominal distention Obtain a detailed history: ❑ Dietary history: Dietary pattern change, low fiber diet, food intolerance, dehydration etc | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient: ❑ General status: Pulse, blood pressure, respiratory rate, weight, thyroid
❑ Abdominal examination: Mass, distension, tenderness and bowel sounds | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Order tests: ❑ Complete blood count (CBC) When secondary causes are suspected: ❑ Colonoscopy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Possible etiologies after initial evaluation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Irritable bowel syndrome(IBS) | Unknown etiology | Organic constipation (mechanical obstruction or drug side effect) | Constipation secondary to systemic disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rx for IBS | Dietary fiber supplementation and simple laxatives | Treat the underlying etiology | Treat the underlying systemic disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refractory constipation if there is no response to initial management | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Management of Refractory Constipation
Chronic constipation who have not responded to a high-fiber diet and/or over-the-counter laxatives after organic disorders have been excluded | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal BET, ARM, BD, CTT | Abnormal CTT Normal BET, ARM, BD | Abnormal BET, ARM, BD Normal CTT | Abnormal BET, ARM, BD, CTT | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal transit constipation | Slow transit constipation | Pelvic floor dysfunction | Combined slow transit constipation and pelvic floor dysfunction | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Management of Normal Transit Constipation
Normal transit constipation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fiber ❑ Psyllium: 1 tsp up to 3 times daily PLUS Saline laxative ❑ Milk of magnesia: 15-30 ml OD or BID | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continue the same regimen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continue the same regimen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continue the same regimen | Adjust and change medications periodically | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Management of Slow Transit Constipation
Slow transit constipation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fiber ❑ Psyllium: 1 tsp up to 3 times daily PLUS Saline laxative ❑ Milk of magnesia: 15-30 ml OD or BID PLUS Stimulant laxative ❑ Bisacodyl: 10 mg suppositories or 5-10 mg orally up to 3 times/wk | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continue the initial therapeutic regimen ❑ Fiber ❑ milk of magnesia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repeat colonic transit test with medications | Continue the initial therapeutic regimen | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Delayed | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjust medications as needed | Repeat BET and BD | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Abnormal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consider illeo rectal anastamosis or subtotal colectomy | Manage for pelvic floor dysfunction | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Management of Pelvic Floor Dysfunction
Pelvic floor dysfunction | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abnormal BET or BD ❑ Define rectoanal angle High resting pressure ❑ Rule out anal fissure first Abnormal reflex ❑ Absence of rectoanal inhibitory reflex | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fiber ❑ Psyllium: 1 tsp up to 3 times daily PLUS Stimulant laxative ❑ Bisacodyl: 10 mg suppositories or 5-10 mg orally up to 3 times/wk | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biofeedback ❑ Anorectal and pelvic floor muscle activity are recorded by surface electromyographic sensors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Follow clinically | Repeat balloon expulsion test | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abnormal | Normal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Perform defecating proctogram | Manage as normal transit constipation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Abnormal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reassess biofeedback + medications if needed | Define anatomic rectal defect | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No response | Clinically significant | Insignificant | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consider surgery | Surgical repair and follow up | No surgery needed | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Management of Combined Pelvic Floor Dysfunction and Slow Transit Constipation
Combined pelvic floor dysfunction and slow transit constipation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biofeedback PLUS Dietary fiber: Psyllium/methylcellulose PLUS Stimulant laxative: Bisacodyl PLUS Saline laxative: Milk of magnesia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Perform colonic transit test without medications | Repeat balloon expulsion test | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
If delayed manage as slow transit constipation | If normal follow clinically | Abnormal | Normal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Perform defecating proctogram | Manage as slow transit constipation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Abnormal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reassess biofeedback + add hyperosmolar agents (lactulose/PEG) | Define anatomic rectal defect | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No improvement | No response | Clinically significant | Insignificant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repeat colonic transit test on medications | Continue therapeutic regimen | Surgical repair and follow up | No surgery needed | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Delayed | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjust medications as needed | Consider surgery | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consider surgery if no improvement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Do begin evaluation of constipation with a detailed history and physical examination that includes a rectal examination.
- Do perform a colonoscopy in patient's presenting with the recent onset of constipation without an obvious explanation, hematochezia, weight loss of ≥10 pounds, a family history of colon cancer or inflammatory bowel disease, anemia and positive fecal occult blood test.
- Do perform a trial of conservative management of lifestyle and dietary modification in patients without any of the above alarm symptoms.
Dont's
- Dont use insoluble fiber like wheat bran for the intial managment of constipation in adults.
References
- ↑ 1.0 1.1 1.2 1.3 Bharucha AE, Pemberton JH, Locke GR (2013). "American Gastroenterological Association technical review on constipation". Gastroenterology. 144 (1): 218–38. doi:10.1053/j.gastro.2012.10.028. PMC 3531555. PMID 23261065.
- ↑ American College of Gastroenterology Chronic Constipation Task Force (2005). "An evidence-based approach to the management of chronic constipation in North America". Am J Gastroenterol. 100 Suppl 1: S1–4. doi:10.1111/j.1572-0241.2005.50613_1.x. PMID 16008640.
- ↑ Locke GR, Pemberton JH, Phillips SF (2000). "American Gastroenterological Association Medical Position Statement: guidelines on constipation". Gastroenterology. 119 (6): 1761–6. PMID 11113098.
- ↑ Longstreth, GF.; Thompson, WG.; Chey, WD.; Houghton, LA.; Mearin, F.; Spiller, RC. (2006). "Functional bowel disorders". Gastroenterology. 130 (5): 1480–91. doi:10.1053/j.gastro.2005.11.061. PMID 16678561. Unknown parameter
|month=
ignored (help) - ↑ Lembo, AJ.; Kurtz, CB.; Macdougall, JE.; Lavins, BJ.; Currie, MG.; Fitch, DA.; Jeglinski, BI.; Johnston, JM. (2010). "Efficacy of linaclotide for patients with chronic constipation". Gastroenterology. 138 (3): 886–95.e1. doi:10.1053/j.gastro.2009.12.050. PMID 20045700. Unknown parameter
|month=
ignored (help) - ↑ Caldarella MP, Milano A, Laterza F; et al. (2005). "Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion". Am. J. Gastroenterol. 100 (2): 383–9. doi:10.1111/j.1572-0241.2005.40100.x. PMID 15667496.
- ↑ "Nicotine withdrawal symptoms:Constipation". helpwithsmoking.com. 2005. Retrieved 2007-06-29.
- ↑ Bharucha, AE.; Dorn, SD.; Lembo, A.; Pressman, A. (2013). "American Gastroenterological Association medical position statement on constipation". Gastroenterology. 144 (1): 211–7. doi:10.1053/j.gastro.2012.10.029. PMID 23261064. Unknown parameter
|month=
ignored (help)